Tag Archives: LongTerm

LPath’s Form / Fill Delay Disappoints Investors: Long-Term Buying Opportunity?

By Steven Breazzano:

Upcoming events: PEDigree phase Ib/2a preliminary data now expected late Q3 2012 or early Q4 2012

LPath, Inc. (LPTN.OB) - based in San Diego, CA engages in the development of lipidomic-based therapeutics. Utilizing its proprietary ImmuneY2™ discovery engine, the company aims to leverage its technology platform to provide monoclonal antibodies targeting bioactive lipids in a safe, efficacious, and reliable manner. LPath is an early stage biotechnology company currently involved in two efficacy trials with its partner, Pfizer (PFE), for its ocular formulation of the humanized monoclonal anti-S1P antibody (Sphingomab™). In addition, the company plans to begin its long-planned Asonep trials, the systemic formulation of its humanized monoclonal anti-S1P antibody (Sphingomab™) in renal cell carcinoma (RCC) in the next few months.

Unfortunately for holders of LPath stock, the clinical trials ground to an abrupt halt as LPath announced late last week that dosing of iSONEP will stop due to cGMP compliance


Complete Story »

Long Investing Ideas from Seeking Alpha

Sears: Short-Term Gain, Long-Term Problem

By Justin Weinstein:

One of the nation’s ailing retailers, Sears Holding Corp. (SHLD), received an 8% boost from Wall Street on Thursday on rumors that CIT Group Inc. (CIT) would be financing costs attributed to the retailer’s suppliers. This news comes after CIT reportedly stopped financing vendors of SHLD due to the company’s dismal sales and mounting debt.

This jump in the stock price may be indicative of a short term rally due to SHLD securing loans necessary to its business operations, but do not allow this news and short term rally to cloud your view of the long term systemic problems that SHC faces.

Short-Term Rally

There are several key reasons why SHC could rally into the second half of the 2nd quarter of 2012. The main reason comes from firms like CIT agreeing to finance the ailing retailers operations. This comes as good news to Wall Street, as the company was

Some long-term healthcare policies not paying up

Sharyl Attkisson: Some companies not delivering on promises to cover expenses ranging from home healthcare to nursing homes

Latest Retirement Headlines – CBS News

Don’t Fool Yourself Into Thinking You Are a Long-Term Investor If You Aren’t

Just as everyone likes to fancy themselves middle class (the facts: unless you make between $ 2,894.83 and $ 4,335.75 per month, the middle quintile for the American population, you are not middle class), everyone likes to talk about how they are long-term investors.  Unfortunately, the facts don’t show that to be the case.  While the average American stays in their home for seven years before selling it, many investors think displaying the same patience and horizon with a partial ownership stake in a company such as Pepsi or Johnson & Johnson is unfathomable.  To them, six months is a long-term investment!

This begs the question: How can you be sure you aren’t just fooling yourself into thinking you have the right time perspective?  To help answer, I wrote a new article called How Do You Know If You Are Making a Long-Term Investment?, which includes a checklist to help you determine if you are in it for the long-haul or trading stocks and fooling yourself.

The article also explains that not every company should be a long-term investment.  Typically, you only want to own so-called “excellent businesses” that have very specific financial characteristics.  (For more information on that topic, instead, read Getting Rich By Investing in an Excellent Business).

Both should be good places to start for new investors who don’t consider a good time to be chugging Pepto-Bismol in front of a trading screen, afraid to go to the bathroom for fear of losing their nest egg due to a change in the Dow Jones Industrial Average.

Sudden Illness Can Hasten Long-Term Care Discussion for Aging Americans

As people age, planning for long-term care is a necessity.
Top Lifestyle > Retirement News Articles

Considerations For Long-Term Care Coverage

Medical and financial health determine whether long-term care insurance will pay off.
Investopedia: Articles and Tutorials

Avanir Pain Drug Should Provide Long-Term Growth

By Bert Wilkison:

It has been nearly a year since the FDA approved Avanir Pharmaceutical’s (AVNR) Nuedexta for Pseudobulbar Affect (PBA). Since Nuedexta’s approval, Avanir’s shareholders have suffered through massive beneficial-owner selling, a painful round of dilution, one of the slowest initial drug launches in history, a surprise Congressional inquiry into the drug’s pricing, four ANDA filings, and downward short-term price target revisions.

Shareholders have also watched in wonder as short interest in the company has grown to an astounding 33 million shares, nearly matching the total number of shares held by non-institutional investors.

In light of the above, it should be no wonder that, since Nuedexta’s approval, the stock’s price has dropped from its 52-week high of $ 5.80 to its recent low of $ 2.46, and that month after month, options players have seen their out-of-the-money calls expire worthless.

So what went wrong? Some would say nothing at all. PBA is a disease

Mary Buffett – Warren Buffett and Long-Term Investing

Complete video at: fora.tv Author Mary Buffett discusses billionaire investor Warren Buffett’s emphasis on investing for the long-term, and warns against overvaluing short-term profits. —– Mary Buffett on “The Tao of Warren Buffet.” A collection of pithy and inspiring sayings from America’s favorite businessman that reveal his secrets of success. Like the sayings of the ancient Chinese philospher Lao-tzu, Warren Buffett’s worldly wisdom is deceptively simple and enormously powerful in application. In “The Tao of Warren Buffett,” Mary Buffett – author of three books on Warren Buffett’s investment methods – joins noted Buffettologist and international lecturer David Clark to bring you Warren Buffett’s smartest, funniest, and most memorable sayings with an eye toward revealing the life philosophy and the investment strategies that have made Warren Buffett, and the shareholders of Berkshire Hathaway, so enormously wealthy. Warren Buffett’s investment achievements are unparalleled. He owes his success to hard work, integrity, and that most elusive commodity of all, common sense. The quotations in this book exemplify Warren’s practical strategies and provide useful illustrations for every investor – large or small – and models everyone can follow. The quotes are culled from a variety of sources, including personal conversations, corporate reports, profiles, and interviews. The authors provide short explanations for each quote and use examples from Buffett’s own business
Video Rating: 3 / 5